Market Research Blog – Page 1000 – New Product Development

Sleep Apnea Implants Market Projected to Reach USD 1,158.1 Million by 2033, Growing at a CAGR of 13.8%

The sleep apnea implants market is set for remarkable growth, with an estimated valuation of USD 317.1 million in 2023 and a projected value of USD 1,158.1 million by 2033. This significant advancement corresponds to a compound annual growth rate (CAGR) of 13.8% during the forecast period, reflecting the increasing demand for effective treatment solutions for sleep apnea.

Sleep apnea is a serious sleep disorder that affects millions of individuals worldwide, characterized by repeated interruptions in breathing during sleep. The rising prevalence of this condition has led to a growing focus on innovative treatment options, including sleep apnea implants, which offer a viable alternative to traditional therapies.

Key factors driving the growth of the sleep apnea implants market include:

Increasing Prevalence of Sleep Apnea: The rising incidence of sleep apnea, particularly among the aging population and those with obesity, is propelling the demand for effective treatment solutions.
Technological Innovations: Continuous advancements in implant technology, including improved comfort, safety, and efficacy, are encouraging adoption among healthcare providers and patients.
Growing Awareness and Diagnosis: Enhanced awareness of sleep apnea symptoms and the importance of early diagnosis are leading to higher rates of identification and treatment, further boosting market growth.
Rising Healthcare Expenditure: Increased healthcare spending and investments in sleep medicine are facilitating the availability and accessibility of advanced treatment options, including sleep apnea implants.

As the sleep apnea implants market evolves, stakeholders are encouraged to prioritize research and development to enhance product offerings and meet the diverse needs of patients and healthcare providers.

One of the pivotal opportunities within this burgeoning landscape is the advancement of minimally invasive implant procedures. In this era of innovation, manufacturers have honed their focus on crafting implants that offer ease of insertion and adjustment with minimal surgical intervention. This strategic shift not only mitigates patient discomfort but also substantially reduces recovery times, leading to cost savings within the healthcare sector.

An exciting development in the realm of Sleep Apnea Implants is the integration of Artificial Intelligence (AI) and Machine Learning (ML) algorithms. By harnessing the power of these cutting-edge technologies, implants can now continuously monitor and analyze sleep patterns. They can adapt therapy settings in real-time, ultimately offering personalized treatment solutions that are tailor-made for individual patients.

There is a growing demand for implantable devices that offer multi-modal therapy options. Key players are exploring the combination of neurostimulation with other therapeutic modalities, such as drug delivery or positional therapy, to provide comprehensive and more effective treatment solutions.

Advancements in remote monitoring and telemedicine technologies are creating opportunities for improved patient care and enhanced follow-up. Implants with remote monitoring capabilities enable healthcare providers to monitor therapy effectiveness, make necessary adjustments remotely, and provide timely interventions when needed.

Key Takeaways from the Sleep Apnea Implants Market:

According to FMI, the United States is leading the growth in North America, capturing approximately 84.1% of the market share in 2022.
Sales of Sleep Apnea Implants in India are projected to experience a significant surge with an estimated compound annual growth rate (CAGR) of 18.2% in 2022.
The market for Sleep Apnea Implants will be predominantly driven by the OSA segment, which will continue to grow and dominate the market throughout the forecast period.
Hypoglossal Neurostimulation Devices hold the largest market share of 84.66% in the Global Sleep Apnea Implants Industry, indicating their prominence in the industry.
The OSA segment is expected to maintain its dominance in the Global Sleep Apnea Implants Industry, accounting for a market share of 91.34%.

“The Sleep Apnea Implants market represents a promising horizon for individuals affected by sleep apnea, as groundbreaking technologies are revolutionizing their lives by bringing back restful nights and rejuvenating their overall well-being during the day”, remarks an analyst at FMI.

How Key Players are Revolutionizing the Manufacturing of the Sleep Apnea Implants Market?

Key players in the Sleep Apnea Implants market are driving a revolution in manufacturing by introducing advanced technologies and innovative approaches. These companies are leveraging their expertise to develop implantable devices that provide effective and personalized treatment options for patients with sleep apnea.

By integrating cutting-edge features such as neurostimulation, these implants target the root cause of the condition and regulate breathing patterns during sleep. Key players are also focusing on improving patient experience by developing user-friendly therapy management systems that allow for remote monitoring and customization. With their continuous efforts, these manufacturers are revolutionizing the manufacturing of Sleep Apnea Implants, offering enhanced treatment outcomes and improving the quality of life for patients.

Key Players in the Sleep Apnea Implants Market:

Inspire Medical Systems
Respicardia, Inc.
Medtronic Plc
LinguaFlex LLC
Siesta Medical, Inc.
Pillar Palatal LLC / The Snoring Center
Nyxoah SA
LivaNova/ImThera

Product Portfolio:

Inspire Medical Systems offers a comprehensive product portfolio in the field of sleep apnea treatment. Their innovative solutions include implantable devices and therapy management systems that provide effective and personalized treatment options for patients suffering from sleep-related breathing disorders.
Respicardia, Inc. specializes in providing a diverse product portfolio for the treatment of central sleep apnea. Their offerings include implantable neurostimulation devices that help regulate breathing and improve sleep quality, offering patients advanced and tailored solutions for managing their respiratory conditions.

More Insights Available:

Future Market Insights offers an unbiased analysis of the Global Sleep Apnea Implants Industry, providing historical data from 2018 to 2022 and forecast statistics from 2023 to 2033.

Sleep Apnea Implants Market Segmentation:

By Product:

Phrenic Nerve Stimulator
Hypoglossal Neurostimulation Devices
Bone Screw Implant System
Flexible Tongue Retractor System
Palatal Implants/Pillar Procedure

By Indication:

Central Sleep Apnea
Obstructive Sleep Apnea (OSA)

By End User:

Hospitals
Ambulatory Surgical Centers
Office Based Clinics

Author

Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.) holds over 12 years of experience in the Healthcare, Medical Devices, and Pharmaceutical industries. His curious and analytical nature helped him shape his career as a researcher.

Identifying key challenges faced by clients and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in areas such as Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.

Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI is the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Emergence of MEMS Microdisplays as a Key Technology in Augmented Reality (AR) Applications

The global MEMS microdisplay market is projected to reach US$ 16,761.0 million in 2032. The MEMS microdisplay market is growing swiftly. According to FMI Analysts, the market for MEMS microdisplays is predicted to reach US$ 2,836.0 Million in 2022 and grow at a CAGR of 19.4% from 2022 to 2032.

High-resolution screens called MEMS (Microelectromechanical Systems) microdisplays are employed in magnified display systems. Because of their size, they are utilized in conjunction with augmenting optics. Two straightforward uses for microdisplays include projection and near-eye displays.

OLED displays have surpassed LCD and LCoS display technologies and are in high demand in the microdisplay market due to their advantages and extra capabilities. Demand for microdisplay technology has increased as a result of the introduction of wearable technology, head-up displays (HUDs), smart glasses, and head-mounted displays (HMDs).

In near-to-eye application devices like HMDs, camcorder viewfinders, video phones, and digital camera viewfinders, there is currently an increase in demand for microdisplays. Innovative uses of MEMS microdisplay technology are prevalent in industries like aerospace, military & defense, medicine, and industry, which has expanded the market for microdisplays.

MEMS Microdisplay Market: Market Dynamics

Increased use of microdisplays in various industries such as military and aerospace and existence of many players has created high demand in MEMS microdisplay market Lack of acceptance of MEMS microdisplay products due to shorter shelf life of LCoS is a restraining factor for MEMS microdisplay market Growing number of near-to-eye applications is the latest trend in the MEMS microdisplay market

Global MEMS Microdisplay Market: Competition Landscape

Few prominent players in MEMS Microdisplay market includeTexas Instruments, Iron City Micro Display, MicroVision Inc, Cardiocomm Solutions, Casio America, Inc., Cellnovo Limited, Covidien plc, EM Microelectronic-Marin SA, Jawbone Inc. and STMicroelectronics N.V. etc.

MEMS Microdisplay Market: Regional Outlook

North America is projected to hold the largest share in the MEMS Microdisplay market and is estimated to be in the leading position owing to the continuous advancement in MEMS-based DMDs (digital micromirror device) that is creating opportunities to integrate projection-based display technology across various applications. Europe and Asia Pacific are estimated to contribute significantly over the forecast period.

Regional analysis of Global MEMS Microdisplay Market includes

North America MEMS Microdisplay Market
Latin America MEMS Microdisplay Market
Eastern Europe MEMS Microdisplay Market
Western Europe MEMS Microdisplay Market
Asia Pacific MEMS Microdisplay Market
Japan MEMS Microdisplay Market
Middle East and Africa MEMS Microdisplay Market

Global MEMS Microdisplay Market: Market Segmentation

MEMS Microdisplay market segmented by application, material, display technologies, and region.

Segmentation by application in MEMS Microdisplay market:

Near-to-Eye
Projection

Segmentation by material in MEMS Microdisplay market:

Chemicals & gases
Photomasks
Glass wafers
SOI wafers
Si Wafers

Segmentation by display technologies in MEMS Microdisplay market:

OLED (Organic Light Emitting Diode)
LCD (Liquid Crystal Display)
LCoS (Liquid Crystal on Silicon)
DLP (Digital Light Processing)
MEMS (Microelectromechanical Systems)

Download our Sample Report to Discover How Recent Industry Developments @
https://www.futuremarketinsights.com/reports/sample/rep-gb-5014

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries. Join us as we commemorate 10 years of delivering trusted market insights. Reflecting on a decade of achievements, we continue to lead with integrity, innovation, and expertise.

Contact Us:

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Medical X-Ray Detectors Market Projected to Reach USD 3.2 Billion by 2029, Growing at a CAGR of 5.7%

The global medical X-ray detectors market is set for substantial growth, expanding at a compound annual growth rate (CAGR) of 5.7%. The market, valued at approximately USD 2.2 billion in 2022, is anticipated to reach USD 3.2 billion by 2029, reflecting a rising demand for advanced imaging technologies in healthcare.

Medical X-ray detectors are vital components in diagnostic imaging, enabling healthcare professionals to obtain high-quality images for accurate diagnosis and treatment planning. As the healthcare industry evolves, the demand for innovative imaging solutions continues to grow, driving the expansion of the X-ray detectors market.

The rising prevalence of chronic diseases and the growing need for advanced diagnostic imaging technologies are key drivers propelling the demand for medical X-ray detectors. These devices play a crucial role in providing accurate and efficient imaging, which is essential for effective patient diagnosis and treatment.

The market’s upward trajectory is driven by several key factors, including advancements in X-ray technology, rising demand for high-quality diagnostic imaging, and increasing adoption of digital X-ray systems. These developments are enhancing the efficiency and accuracy of medical imaging, contributing to the growing market.

As healthcare providers continue to invest in state-of-the-art diagnostic equipment to improve patient outcomes and streamline imaging processes, the medical X-ray detectors market is expected to experience sustained growth. The shift towards digital and advanced imaging technologies is further supporting market expansion.

The surge in the medical devices industry, particularly in imaging and diagnostic tests, is a key catalyst for this anticipated growth. Factors contributing to this upswing include a heightened focus on radiological diagnostic tests, an increasing burden of chronic diseases, and the advent of more efficient X-ray devices facilitated by consolidation and mergers in the medical devices market.

The Centers for Disease Control & Prevention (CDC) estimates that around 80 million Computed Tomography (CT) tests were performed in 2015 in the U.S. alone. A rise in some patients undergoing CT and radiography tests globally and an increase in several tests performed each year have led to significant demand for digital radiography detectors such as a-Si detectors. These factors have boosted the demand for a-Si X-ray flat panel detectors, directly fueling the growth of the Global Medical X-ray detectors Industry.

Key Takeaways – Medical X-Ray Detectors Market Study

Adoption of flat panel X-ray detectors in the global medical X-ray detectors market has increased significantly owing to distinct benefits over computed radiography (CR), charged couple detectors (CCD), and analog detectors (film based).
Introduction of new technology such as Veradius X–ray system by manufacturers is expected to boost demand for thin flat detector devices and computed radiography (CR) detectors among end users.
Direct flat-panel medical X-ray detectors with comparatively higher technical advantage over indirect flat-panel medical X-ray detectors are expected to generate significant revenue.
Increasing adoption of digital X-ray systems for radiological imaging as compared to retrofit X-ray systems marks high revenue potential for the medical X-ray detectors market.

Cloud-based medical imaging and the growing shift from analog to digital X-ray detectors are key growth opportunities for the Global Medical X-ray detectors Market.

Strategic Acquisitions Remains Favored Competition Strategy

Leading players in the medical X-ray detectors market such as GE Healthcare, Canon, Philips, and Hitachi, are focusing on business expansions by entering into partnerships, mergers, sales agreements, and acquisitions with local manufacturers from emerging economies. The aim behind these mergers and acquisitions is to reduce product development costs, streamline the distribution channel, and strengthen the market position.

In December 2016, Canon Inc. acquired the Toshiba Corp. medical unit. With the acquisition, Canon Inc. entered into the diagnostics imaging devices market and leveraged the core strength of Toshiba Medicals in diagnostic imaging. This acquisition would further strengthen Canon’s biomedical business.

Additionally, key players are focusing on research and development and the launch of new products based on exclusive developmental technologies, with an emphasis on product differences. In November 2017, at the Radiological Society of North America (RSNA) tradeshow. Carestream Health showcased a mobile X-ray system with a carbon nanotube. The system entered the medical X-ray detectors market in May 2018 and is compatible with every DRX a-Si detector device provided by Carestream Health.

Know More About FMI’s Report on Global Medical X-Ray Detectors Industry

Future Market Insights brings a comprehensive research report on forecasted revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the segments from 2014 to 2029. The Global Medical X-Ray Detectors Industry is segmented in detail to cover every aspect of the market and present a complete market intelligence approach to the reader. The study provides compelling insights on the Global Medical X-Ray Detectors Industry based on product, panel size, modality, and end user.

A Old Full Report Analysis Click Here

Medical X-Ray Detectors Market By Category By Product :

Indirect Flat-Panel Detectors
Direct Flat-Panel Detectors
Computed Radiography (CR) Detectors

By Panel Size :

Large-Area Flat-Panel Detectors
Small-Area Flat-Panel Detectors

By Modality :

Portable Detectors
Fixed Detectors

By Module Type :

Digital X-ray Systems
Retrofit X-ray Systems

By End User :

Hospitals
Diagnostic Centers

By Region :

North America
Latin America
Europe
East Asia
South Asia
Oceania
Middle East & Africa

Author

Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Medical Lacrimal Devices Market Expected to Grow USD 39.7 Million at a 5.5% CAGR from 2022 to 2029

The global medical lacrimal devices market is projected to witness significant growth, with a compound annual growth rate (CAGR) of 5.5% from 2022 through 2029. The market was valued at approximately USD 25.6 million in 2021, highlighting the increasing demand for innovative solutions in ophthalmic care.

Medical lacrimal devices play a crucial role in the management of various lacrimal system disorders, providing effective treatment options for patients suffering from conditions such as dry eye syndrome, punctal stenosis, and other lacrimal duct obstructions. As awareness of these conditions grows, so does the need for advanced medical devices that enhance patient outcomes.

Key factors driving the expansion of the medical lacrimal devices market include:

Rising Incidence of Eye Disorders: The increasing prevalence of eye-related conditions, particularly among the aging population, is fueling the demand for effective lacrimal solutions.
Technological Advancements: Continuous innovations in the design and functionality of lacrimal devices are improving their efficacy and safety, making them more appealing to both healthcare providers and patients.
Growing Awareness and Diagnosis: Enhanced awareness of lacrimal system disorders and improved diagnostic capabilities are leading to higher rates of identification and treatment of these conditions.
Increased Healthcare Investments: Rising investments in healthcare infrastructure and advancements in ophthalmic care are facilitating the availability and accessibility of medical lacrimal devices.

As the market for medical lacrimal devices evolves, stakeholders are encouraged to focus on research and development initiatives to create innovative solutions that address the diverse needs of patients and healthcare providers alike.

Lacrimal devices, notably Nasolacrimal stents, have emerged as a groundbreaking advancement in ophthalmic care. These devices provide a novel solution for tear drainage in cases where traditional tear ducts are nonfunctional, and alternative drainage options are limited. The inception of lacrimal stents dates back to 1932 when Dr. Graue introduced the concept, of utilizing silver wire as the primary material.

Over the years, the lacrimal devices landscape has witnessed significant advancements, with various materials like silk, nylon, polyethylene, and polypropylene being employed to enhance performance and patient comfort. These small tubes are typically constructed from silicone or other semi-rigid yet flexible materials, featuring an open center lumen for optimal tear drainage.

The Global Lacrimal Devices Industry’s impressive growth can be attributed to ongoing innovations and increasing demand for effective tear drainage solutions. With a 5.5% CAGR driving the market’s expansion, it is clear that lacrimal devices are becoming an integral part of the ophthalmic industry, offering hope and improved quality of life to countless individuals worldwide.

The increased demand for ophthalmic treatments with greater success rates and minimum intrusions, as well as an increase in patients with nasolacrimal duct obstruction, are driving the Global Lacrimal Devices Industry.

During the projected period, the introduction of innovative and high-success-rate treatments will move the market forward. The adoption of precise and updated lacrimal devices, such as the new lacrimal cannula, which combines flexibility and strength to prevent trauma by providing easy access to the canaliculus, is a fundamental driver of market expansion.

Manufacturers Emphasizing Advanced Product Development

Numerous organizations are focusing on new product development for lacrimal duct stent tubes. In June 2019, FCI Ophthalmic offered a complete line of BIKA stents namely, BIKA, BIKA for DCR, and Infant BIKA covering a range of sizes that will benefit most of the congenital nasolacrimal duct obstruction (CNLDO) and dacryocystorhinostomy (DCR) cases.

Key Takeaways – Lacrimal Devices Market Study

Bicanalicular lacrimal duct stent tube is expected to contribute a fourth of the revenue share in the lacrimal duct stent tube market owing to its high success rate in stent placement.
Hospitals captured the maximum share of the lacrimal duct stent tube market owing to the highest patient footfall followed by ophthalmic clinics.
Attributed to the growing patient pool for retinal diseases, especially due to premature births, contributed to the dominance of North America in the lacrimal duct stent tube market.
Increasing awareness for the availability of the treatment for nasolacrimal duct stent obstruction among caregivers of prematurely born babies and an increasing number of skilled professionals are expected to drive the growth of the lacrimal duct stent tube market in East Asia.

Lacrimal Devices Market Competitive Landscape

FCI Ophthalmics
Kaneka Corporation (Kaneka Pharma America LLC)
Gunther Weiss Scientific Glass
Bess Medizintechnik GmBH

Key Segments Covered In Lacrimal Devices Market Research

By Product:

Monocanalicular Lacrimal Duct Stent Tube
Bicanalicular Lacrimal Duct Stent Tube

By End User:

Hospitals
Ophthalmic Clinics
Ambulatory Surgical Centers

Author

Identifying key challenges clients face and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in areas such as Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.

Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:

Automatic Identification and Data Capture Market Set to Achieve USD 147.9 Billion by 2033 at 10.8% CAGR

The market for Automatic Identification and Data Capture (AIDC) is anticipated to develop significantly over the next ten years, from USD 52,910.7 million in 2023 to USD 147,992.7 million in 2033. The growing use of AIDC technologies across sectors for better accuracy, efficiency, and real-time data tracking is the main driver of this significant expansion, which is expected to reach a CAGR of 10.8% over the projection period.

Retail, healthcare, manufacturing, and logistics are just a few of the industries that have found AIDC technology—which encompasses techniques like barcoding, RFID (radio frequency identification), biometrics, and voice recognition—to be indispensable. The need for AIDC solutions is growing as companies seek to increase operational effectiveness and reduce mistakes, making it an important market to monitor.

Key Takeaways from Market Study

The AIDC Market is expected to grow from US$ 52.9 billion in 2023 to US$ 147.9 billion by 2033, at a CAGR of 10.8%.
The demand for AIDC technologies is driven by the need for real-time tracking, automated data collection, and improved inventory management across industries.
The retail sector is one of the largest adopters of AIDC technologies due to the growth of e-commerce and the need for efficient inventory control.
The Asia-Pacific region is expected to witness the fastest growth, driven by increasing industrialization, particularly in China and India.

Drivers and Opportunities

The global Automatic Identification and Data Capture Market is witnessing substantial growth due to the rising need for accurate and fast data collection in industries such as retail, manufacturing, healthcare, and transportation. The retail sector, in particular, is leading the adoption of AIDC technologies, fueled by the expansion of e-commerce and the need for streamlined supply chain management.

Furthermore, the healthcare industry is increasingly deploying AIDC solutions for patient identification, medical record management, and inventory tracking of critical medical supplies. The logistics and transportation sectors are also embracing these technologies for fleet management, asset tracking, and real-time location monitoring.

Opportunities are also arising from advancements in RFID technology, which enables contactless and fast data transfer, and biometrics, which is becoming integral for security and identity verification across sectors.

Components Insights

The AIDC Market can be segmented into various components, including barcoding systems, RFID systems, biometric systems, smart cards, and OCR (optical character recognition).

Barcoding and RFID systems are the most widely used components in the AIDC space, as they provide reliable, cost-effective solutions for tracking inventory, assets, and goods across industries. Biometrics is gaining traction, particularly in sectors such as banking, government, and healthcare, where secure and accurate identity verification is critical.

Application Insights

AIDC technologies find applications across diverse industries, with the retail sector holding a significant share due to the high demand for inventory management, point-of-sale solutions, and customer tracking. As the e-commerce sector continues to grow, retailers are investing in advanced AIDC solutions to enhance customer experience and optimize operations.

The healthcare industry is another critical application area, where AIDC systems are used to ensure accurate patient identification, manage medical records, and track the supply chain of medications and medical devices. Additionally, the manufacturing and logistics sectors utilize AIDC technologies to streamline operations, reduce human error, and enhance productivity.

Deployment Insights

AIDC solutions are deployed in various forms, including on-premise and cloud-based models. The shift towards cloud-based AIDC systems is gaining momentum due to the scalability, flexibility, and lower upfront costs associated with cloud solutions.

The cloud deployment model is particularly appealing to small and medium-sized enterprises (SMEs) that require cost-effective yet high-performance data capture solutions. On-premise deployment, however, remains prominent in large enterprises that prioritize data security and customization.

Key Companies & Market Share Insights

The AIDC Market is highly competitive, with leading players focusing on expanding their product portfolios and enhancing their technological capabilities. Key market participants include Zebra Technologies, Honeywell International Inc., Datalogic S.p.A., SATO Holdings Corporation, and Cognex Corporation.

These companies are investing heavily in research and development (R&D) to introduce innovative AIDC solutions that cater to the evolving needs of industries such as retail, healthcare, and transportation. Zebra Technologies, for instance, continues to dominate the market with its wide range of barcoding and RFID solutions, while Honeywell is expanding its presence with innovative biometric and smart card systems.

Recent Developments

Zebra Technologies recently launched a new RFID-based inventory management solution, designed to help retailers enhance their supply chain efficiency and reduce stockouts.
Honeywell International announced the development of an advanced biometric authentication system aimed at improving security in the banking and healthcare sectors.
Datalogic introduced an updated barcode scanning technology with enhanced durability and performance, targeting the warehouse management and manufacturing sectors.

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries. Join us as we commemorate 10 years of delivering trusted market insights. Reflecting on a decade of achievements, we continue to lead with integrity, innovation, and expertise.

Contact Us:

Radiation Toxicity Treatment Market Projected to Reach USD 5.58 Billion by 2029 at a 5.8% of CAGR

The global radiation toxicity treatment market was valued at approximately USD 3.55 billion in 2021 and is expected to grow significantly, reaching an estimated USD 5.58 billion by 2029, according to a recent market survey conducted by Future Market Insights (FMI). This growth reflects the increasing demand for effective treatments for radiation exposure, driven by a range of factors, including industrial applications, nuclear medicine, and concerns regarding nuclear safety.

Radiation toxicity can occur as a result of exposure to ionizing radiation from various sources, and the need for effective treatment solutions is more critical than ever. The rising incidence of conditions associated with radiation exposure is propelling the demand for innovative therapies and interventions in this field.

Key factors contributing to the anticipated growth of the radiation toxicity treatment market include:

Increasing Awareness of Radiation Risks: Growing awareness regarding the health risks associated with radiation exposure is driving the demand for effective treatment options, particularly among healthcare providers and patients.
Rising Incidence of Cancer: The increasing prevalence of cancer and the subsequent use of radiotherapy as a treatment option are boosting the demand for radiation toxicity management solutions.
Advancements in Treatment Technologies: Continuous innovations in treatment technologies and pharmaceuticals are enhancing the effectiveness of radiation toxicity treatments, making them more appealing to healthcare professionals.
Supportive Regulatory Frameworks: Government initiatives and regulatory support aimed at enhancing radiation safety and health care practices are expected to further stimulate market growth.

As the radiation toxicity treatment market continues to evolve, stakeholders are encouraged to focus on research and development to improve treatment efficacy and expand therapeutic options available to patients.

The past decade has witnessed a remarkable expansion in the installed base of internal radiation therapy machines, emerging as a key driver behind the industry’s surge. This growth can be attributed to the significant improvement in reimbursement scenarios and a favorable government policy framework in the field of cancer care. These advancements have enhanced the accessibility of radiation therapy, contributing significantly to the flourishing landscape of the Global Radiation Toxicity Treatment Industry.

According to the survey, major businesses in Asia Pacific will continue to invest extensively in the development of new radiation therapies, in response to the region’s rising cancer prevalence and better rate of diagnosis.

The rising incidence of radiation toxicity in the healthcare and chemical industries drives the need for appropriate therapy. Another key factor contributing to market expansion is the recent FDA approval of various orphan medications that have been shown to effectively boost the survival rate in adult and pediatric radiation sickness patients. These application areas continue to provide prospects for growth in the Global Radiation Toxicity Treatment Industry.

Key Takeaways – Radiation Toxicity Treatment Market Study

Increased use of colony-stimulating agents, such as Amgen’s Neulasta, will account for more than 75% of revenue share in the Radiation Toxicity Treatment market by 2029.
Non-ionizing radiation is expected to provide a lucrative opportunity to market participants due to high incidences of radiation toxicity caused by gamma radiation emission from positron emission tomography (PET) and single-photon emission computed tomography (SPECT) scanners installed in hospitals and diagnostic centers.
North America continues to lead the Radiation Toxicity Treatment market, while South Asia is expected to rise rapidly soon.

Who Is Winning?

Some of the key players operating in the Global Radiation Toxicity Treatment Industry include Amgen Inc., Partner Therapeutics, Mylan N.V., and Novartis AG. Leading players in the Global Radiation Toxicity Treatment Industry are focusing on acquiring smaller companies to enhance their product portfolio and improve regional market positioning.

For instance, Siegfried Group announced the acquisition of a drug product manufacturing facility together with all related employees and contracts from Arena Pharmaceuticals GmbH in Zofingen, Switzerland. Also, in 2018, Partner Therapeutics (PTx) acquired global rights to develop, manufacture, and commercialize Leukine (sargramostim) from Sanofi.

More insights available

North America is expected to dominate the radiation toxicity market due to the high incidence of cancer in the region, favorable reimbursement policies, and well-established healthcare infrastructure. Europe is also expected to witness significant growth in the radiation toxicity market due to increasing government initiatives to promote radiation therapy and rising investments in research and development activities.

Radiation Toxicity Treatment Market by Category

By Product:

Colony Stimulating Factors
Potassium Iodide
Prussian Blue
Diethylenetriamine Pentaacetic Acid
Others

By Indication:

Acute Radiation Syndrome
- Bone Marrow Syndrome (Hematopoietic)
- Gastrointestinal Syndrome (GI)
- Cardiovascular (CV)
Chronic Radiation Syndrome

By Radiation Type:

Ionizing Radiation
- Alpha Radiation
- Beta Radiation
- Gamma Radiation
Non-ionizing Radiation

By End-User:

Hospitals
- Government Hospitals
- Private Hospitals
Research & Academic Institutes
- Government Research and Academic Institutes
- Private Research and Academic Institutes

Author

Identifying key challenges clients face and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.

Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.

About Future Market Insights (FMI)

Contact Us:

Implantable Drug Eluting Devices Market Projected to Grow at a 6.0% CAGR, Reaching an Estimated USD 12.8 Billion by 2029

The global implantable drug eluting devices market is poised for significant growth, expected to expand at a compound annual growth rate (CAGR) of 6.0% from 2022 to 2029. The market was valued at approximately USD 12.8 billion as of 2022, highlighting a robust demand for innovative medical solutions that enhance therapeutic efficacy.

According to projections from Future Market Insights, contraceptive drug eluting devices accounted for a substantial market share of over 39.8% in 2021, underscoring their importance within the broader landscape of implantable drug delivery systems. These devices are increasingly recognized for their ability to provide sustained release of medication, improving patient adherence and outcomes.

Key factors driving growth in the implantable drug eluting devices market include:

Rising Demand for Long-Acting Contraceptive Solutions: The growing awareness and acceptance of long-acting contraceptive methods are contributing to the increased adoption of drug eluting devices, particularly in reproductive health.
Technological Advancements: Innovations in drug eluting technologies, including improved formulation and delivery mechanisms, are enhancing the effectiveness and safety of these devices, attracting healthcare providers and patients alike.
Growing Prevalence of Chronic Diseases: The rising incidence of chronic diseases, such as cardiovascular conditions and cancer, is propelling the need for effective drug delivery systems that provide targeted therapy and minimize side effects.
Expanding Healthcare Infrastructure: The development of healthcare infrastructure in emerging economies is facilitating access to advanced medical technologies, further boosting the adoption of implantable drug eluting devices.

As the market continues to evolve, industry stakeholders are encouraged to invest in research and development to create innovative solutions that address the diverse needs of patients and healthcare providers.

Among the various product categories, contraceptive drug eluting devices have demonstrated significant market presence, holding a substantial share of over 39.8% in 2021. These devices provide a reliable and effective means of contraception, contributing to their growing adoption worldwide.

A significant contributor to this growth is the substantial market share held by contraceptive drug eluting devices, which represented over 39.8% of the market in 2021. This highlights the growing adoption of implantable devices for contraceptive purposes, driven by their effectiveness and convenience in long-term birth control.

In a noteworthy trend, manufacturers leading the industry are harnessing advancements in micro and nanotechnology to craft innovative implantable drug-eluting devices, steering the industry towards unprecedented growth. These cutting-edge devices exhibit controlled and site-specific attributes, along with compatibility for targeted drug delivery. This unique combination not only simplifies intricate dosing schedules but also mitigates the systemic toxicity associated with conventional drug delivery systems.

Remote-Controlled Chips and Programmable Devices – Future of Targeted Drug Delivery

Increasing clinical trials and research & development of remote-controlled and programmable drug-eluting devices Massachusetts Institute of Technology (MIT) researchers have developed a remote-controlled contraceptive hormone (levonorgestrel) delivery chip implant, which can turn the device on and off. Implantable drug-eluting devices allow minimum effective doses and support oral opioid weaning

Implantable drug-eluting devices such as SynchroMed II intrathecal drug delivery system with a controlled workflow system, play an effective role in reducing or eliminating the use of oral opioids. Antiretroviral (ARV) drug implant is expected to emerge as a promising approach for HIV treatment and prevention In July 2022, Merck & Co. started the development of slow-release antiretroviral (ARV) drug implants as a promising approach for HIV treatment.

The growth of the Global Implantable Drug Eluting Devices Industry can be prominently attributed to the associated cost-effective technology and novel medication administration techniques. Fewer side effects while these devices are utilized in the management of chronic diseases as well as in contraception have been the strongest attribute accounting for a steadily expanding market for implantable drug-eluting devices. Says Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.)

Know More About Global Implantable Drug-Eluting Devices Industry Report

The Global Implantable Drug-Eluting Devices Industry, a new study from Future Market Insights, opines on the evolution of the implantable drug-eluting devices market from 2014 – 2021 and presents demand projections from 2022 – 2029 based on product type (implantable drug infusion pumps, intraocular drug-eluting devices, contraceptive drug-eluting devices, buprenorphine implant, and drug-eluting stents), technology (active drug-eluting devices and passive drug-eluting devices) applications (diabetes macular edema, birth control/contraception, opioid addiction, cardiovascular, ophthalmology, oncology, pain management, others) implantation type (intravaginal, intravascular, intraocular, intrathecal, subcutaneous, intrauterine) end users (hospitals, ambulatory surgical centers, optical care centers, cardiac surgery centers, office-based setting, and others) in seven prominent regions.

Medical-Pharma Collaborating to Balance Demand and Supply

A comprehensive view of the Global Implantable Drug Eluting Devices Industry has led our analysts to conclude that, the market is expected to grow at an impressive rate. This market growth is mainly attributed to increasing innovations and developments in implantable drug-eluting devices for the management and treatment of breast cancer, schizophrenia, Parkinson’s disease, and photosensitivity diseases. Besides, FMI analyst suggests that markets in North America and Europe are expected to hold major value shares in the global implantable drug-eluting devices landscape. Medical device companies are collaborating with pharmaceutical companies to develop efficient drug-delivery devices to cater to the rising demand for implantable drug-eluting devices.

Increasing use of syringe-based subcutaneous implantable drug-eluting devices is anticipated to minimize the number of invasive surgical procedures. The introduction of implantable drug-eluting devices or rare conditions such as central precocious puberty (CPP) will emerge as an important factor shaping the market for implantable drug-eluting devices.

A Old Full Report Analysis Click Here

Key Segments Covered in Global Implantable Drug-Eluting Devices Industry Research

By Product:

Implantable Drug Infusion Pumps
Intraocular Drug-Eluting Devices
Contraceptive Drug-Eluting Devices
Buprenorphine Implant
Drug-Eluting Stents
Others

By Technology:

Active Drug Eluting Device
Passive Drug Eluting Device
- Biodegradable Implants
- Non-Biodegradable Implants

By Application:

Diabetic Macular Edema
Birth Control/Contraception
Opioid Addiction
Cardiovascular
Ophthalmology
Oncology
Pain Management

Author

Identifying key challenges clients face and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.

Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:

Pressure Infusion Bags Market Expected to Reach USD 494.5 Million by 2029 at a 6.5% of CAGR

The global pressure infusion bags market was valued at approximately USD 300.0 million in 2021 and is projected to reach USD 494.5 million by 2029, according to a recent market survey conducted by Future Market Insights (FMI). This significant growth underscores the increasing demand for pressure infusion bags in healthcare settings.

Pressure infusion bags are essential medical devices used to administer fluids rapidly and effectively during critical situations, such as surgery or trauma care. Their importance in patient management and fluid resuscitation is driving their adoption across hospitals, clinics, and emergency medical services.

Key factors contributing to the anticipated growth of the pressure infusion bags market include:

Rising Demand for Emergency Medical Services: The growing number of emergency medical situations, coupled with an increasing focus on timely patient care, is driving the demand for efficient fluid administration solutions.
Technological Advancements: Innovations in the design and functionality of pressure infusion bags, such as improved pressure control mechanisms and user-friendly features, are enhancing their effectiveness and appeal to healthcare providers.
Increasing Healthcare Expenditure: The expansion of healthcare infrastructure and rising healthcare expenditures globally are facilitating the adoption of advanced medical devices, including pressure infusion bags.
Growing Awareness of Patient Safety: The heightened emphasis on patient safety and care quality is prompting healthcare professionals to invest in reliable infusion solutions that enhance patient outcomes.

As the pressure infusion bags market continues to evolve, industry stakeholders are encouraged to focus on innovation and quality to meet the growing demands of healthcare providers and improve patient care.

Pressure infusion bags are critical in emergency and surgical environments, facilitating rapid fluid infusion to patients. The rising prevalence of chronic diseases and the growing need for emergency medical services are driving the demand for these essential devices.

The anticipated growth in the pressure infusion bags market is driven by increasing demand for efficient and effective infusion solutions in medical procedures. Pressure infusion bags are crucial for administering fluids rapidly and precisely, which is vital in emergency care and surgical settings.

Pressure infusion cuffs are designed cuff and bladder device used to pressurize sterile parenteral fluids for rapid infusion into the body. These decrease the infusion time to a few seconds from hour taken by gravity fed blood infusion. The need for rapid infusion of solutions and monitoring of invasive procedures involving pressure are the prime applications of pressure infusion bags. The growing frequency of intra-arterial pressure monitoring and Swan Ganz catheterization procedures coupled with the need to retard the retrograde flow of blood is driving a large market adoption. The development of healthcare infrastructure especially trauma care units, intensive care units, and ambulatory surgical centers are driving a large market expanse.

Key Players

Some of the major players in the global pressure infusion cuffs market are VBM Medizintechnik GmbH, ERKA, SSEM Mthembu Medical (Pty) Ltd., Smiths Medical (Smiths Group plc.), Friedrich Bosch GmbH & Co. KG, Biegler GmbH, SARSTEDT AG & Co. KG and others.

The research report presents a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, and statistically supported and industry-validated market data. It also contains projections using a suitable set of assumptions and methodologies. The research report provides analysis and information according to market segments such as geographies, application, and industry.

Pressure Infusion Cuffs Market: Drivers and Restraints

The development of technology such as the flush valve for regulating the flow of solution coupled with the miniaturization of monitoring devices, ergonomically design, growing use of polyester and nylon material and others is driving a large market. The growing cases of blood transfusion in emergencies coupled with the growing population of geriatric and immunocompromised population is driving a large market.

The restraints on the global pressure infusion cuffs market are the pressure on pricing owing to large market fragmentation, the high volume low value nature of the market which results in price being the most significant value proposition, lack of standardization, low awareness and others.

Pressure Infusion Cuffs Market: Regional Wise Outlook

The global pressure infusion cuffs market is classified into regions viz. North America, Latin America, Western Europe, Eastern Europe, Asia-Pacific, Japan, Middle East and Africa. Asia Pacific market excluding Japan is expected to account for the largest share of the global pressure infusion cuffs market owing to expanding healthcare sector and use of medical devices, and the emergence of China as a large manufacturing base for medical devices. China and India are expected to drive a lion’s share of the pressure infusion cuffs market.

The North America pressure infusion cuffs market is expected to generate a sluggish growth owing to saturation with US leading the pressure infusion cuffs market. Europe market is led by Germany, France and the UK and is expected to be the third largest market.

The Middle East and Africa pressure infusion cuffs market is expected to be dominated by the gulf economies of Saudi Arabia, Kuwait, and Qatar. The poor healthcare expenditure of Africa is a deterrent of the growth of pressure infusion cuffs market.

The report covers exhaust analysis on:

Market Segments
Market Dynamics
Market Size
Supply & Demand
Current Trends/Issues/Challenges
Competition & Companies involved
Technology
Value Chain

A Old Full Report Analysis Click Here

Pressure infusion cuffs Market: Segmentation

To gain an accurate understanding of the latest market trends of the global pressure infusion cuffs market, the report is segmented based on applications, coupling mechanism, connectivity mechanism, material of construction, utility, design, end user, and region.

Based on applications, the global pressure infusion cuffs market is segmented into the following:

Blood and Blood Products
Irrigation
Others

Based on size, the global pressure infusion cuffs market is segmented into the following:

Up to 500 ml
Up to 1000 ml
Greater than 1000 ml

Based on material of construction, the global pressure infusion cuffs market is segmented into the following:

Rubber
Polymers
Others

Based on utility, the global pressure infusion cuffs market is segmented into the following:

Disposable
Reusable

Based on end user, the global pressure infusion cuffs market is segmented as below:

Hospitals
Clinics
Ambulatory Surgical Centers

Author By:

Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:

Global Surgical Tourniquet Market Projected to Reach USD 905.1 Million by 2034, Growing at a CAGR of 5.2%

The global surgical tourniquet market is set to experience significant growth, with an estimated worth of USD 545.1 million by 2024. Projections indicate that the market will continue to expand, reaching a value of USD 905.1 million by 2034, representing a robust compound annual growth rate (CAGR) of 5.2% during the forecast period.

Surgical tourniquets play a critical role in medical procedures, providing essential blood control and enhancing surgical efficiency. The increasing number of surgical procedures globally, coupled with advancements in healthcare technologies, is driving the demand for these vital medical devices.

Key factors contributing to the growth of the surgical tourniquet market include:

Rising Surgical Procedures: The growing prevalence of chronic diseases and an aging population are leading to an increase in surgical interventions, thereby boosting the demand for surgical tourniquets.
Technological Innovations: Advancements in tourniquet technology, including improved safety features and ease of use, are attracting healthcare providers seeking efficient solutions for blood management during surgeries.
Growing Awareness: Increased awareness about the importance of proper blood control during surgical procedures is leading to higher adoption rates of surgical tourniquets among medical professionals.
Expanding Healthcare Infrastructure: The development of healthcare infrastructure, particularly in emerging economies, is facilitating access to advanced surgical devices, further driving market growth.

As the surgical tourniquet market continues to evolve, industry stakeholders are encouraged to invest in research and development to enhance product offerings and meet the growing demands of healthcare providers.

To mitigate the risks associated with elevated tourniquet pressures, manufacturers are directing their focus toward product innovations. They are introducing novel features such as automatic pressure control, audiovisual alarms, digital displays, and user-friendly interfaces, aiming to enhance the safety and effectiveness of these medical devices.

Sales of Tourniquet Cuffs to Ramp up in 2019

According to the FMI analysts, tourniquet cuffs have been a vital part of the modern computer-assisted tourniquet system, which accounted for ~77% of total market revenue in 2018. While the inflatable disposable cuffs represented more than half of the total tourniquet cuff sales in 2018, the consumption of inflatable reusable cuffs is likely to increase by 7.6% y-o-y in 2019.

“In terms of tourniquet systems, dual channel systems will continue to represent a relatively high share as compared to single channel systems, in the view of enabling bi-lateral procedures or simultaneous surgeries of both upper and lower extremity,” the FMI analyst said.

The consumption of surgical tourniquets for knee arthroplasty accounted for ~31% of sales in 2018, while increasing application in the amputation of limbs and trauma cases is likely to result in increased market share in the future.

“Recent advancements in reverse shoulder arthroplasty along with the introduction of ‘personalized’ tourniquet systems that allow the use of variable contour design and cuffs for specific patients will open new avenues of growth for the market players,” said the FMI analyst.

Hospitals Capture Significant Share, North America in the Vanguard

In 2018, surgical tourniquets worth ~US$ 176 million were sold in hospitals; according to FMI analysts, a growing number of hospitals, especially in developing countries, and greater awareness of advanced medical devices will continue to drive the consumption of surgical tourniquets in hospitals.

The rapid adoption of the ‘value-based’ model in health care settings has led to a surge in the number of ambulatory surgical centers and specialized clinics, thereby paving a new way of growth for the surgical tourniquets market.

The FMI analyst forecasts that North America will continue to remain at the forefront of the surgical tourniquets market, representing a 30% share in 2018. While North America is likely to be neck-and-neck with Europe to lead the market in the future, manufacturers are tapping into new opportunities in developing countries in the Asia Pacific.

The surgical tourniquets market shows a fair level of fragmentation, with two prominent players Zimmer Biomet and Stryker Corporation accounting for more than one-third of the total revenue share. Exploring unmet needs in developing regions and expanding their distribution through collaboration and acquisitions of local and regional manufacturers remain key focal points of the market players.

A Old Full Report Analysis Click Here

Key Segment

By Product Type

Tourniquet Systems
- Single Channel Systems
- Dual Channel Systems
Tourniquet Cuffs
Inflatable Cuffs
- Disposable Cuffs
- Reusable Cuffs
Non-Inflatable Cuffs
- Disposable Cuffs
- Reusable Cuffs

By Application

Knee Arthroplasty
Amputation of Limbs
Plastic Surgeries
Trauma Cases

By End User

Hospitals
Ambulatory Surgical Centers
Specialized Clinics

By Region

North America
Europe
Latin America
South Asia
East Asia
Oceania
Middle East And Africa
Emerging Countries

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:

Vacuum Mixing Devices Market Projected to Grow at a 2.4% CAGR, Reaching an Estimated USD USD 186.0 Million by 2029

The global Vacuum Mixing Devices Market is poised for substantial growth, with an expected compound annual growth rate (CAGR) of 2.4% from 2022 to 2029. The market value was estimated at approximately USD 157.9 million as of 2022, indicating a positive outlook for the industry.

According to projections by Future Market Insights, vertical vacuum-mixing devices commanded a significant share of over 57.7% in the global market in 2021. This segment’s dominance is attributed to its efficient mixing capabilities and versatility, making it a preferred choice across various applications, including pharmaceuticals, cosmetics, and food production.

The FMI analyst is of the opinion that market gains will further be upheld by the clinical benefits associated with use of vacuum mixing devices. FMI expects the vacuum mixing devices to see unwavering growth in the next 10 years, as the global healthcare space actively embraces ‘efficiency-enabling’ medical mixing equipment.

Medical mixing processes have remained challenging for a long period of time, primarily undermined by the lack of competent technologies. With gradual evolution of vacuum mixing devices, a wide range of mixing applications are handled seamlessly in shorter timespan without compromising on the results.

According to the FMI report, the vacuum mixing devices market reflects a fair degree of fragmentation, wherein a large pool of regional manufacturers is competing neck to neck. Stryker Corporation and Zimmer Biomet remain two of the market goliaths, with strong product portfolios and extended regional presence.

A majority of the revenues of these two companies are generated from the US and Germany, and their focus on strategic collaborations will continue to yield significant profit benefits and ensure sustained growth. For instance, in 2018, Zimmer Biomet Holdings, Inc. – a global leader in musculoskeletal healthcare – collaborated with Apple to transform the patients’ journey for two most common type of surgeries undergone by the Americans every year – knee and hip replacement. This collaboration was aimed at popularizing the Zimmer Biomet ‘mymobility’ app, an app that makes use of Apple Watch to facilitate constructive connections between patients and their respective surgical teams.

The FMI analyst finds that though the factors conditioning success differ for market players of varying statures, but in all the cases, the market partakers will have to be adept at effective tracking of the evolving market trends and make necessary adaptations.

Key Companies Profiled:

Zimmer Biomet
Heraeus Holding
Stryker
DJO Global, Inc.
Summit Medical
OSARTIS GmbH
SIRIO DENTAL S.R.L.
DENTALFARM SRL
Eurocem Srl
Whip Mix Corporation

Portability: The New Normal Grappling End User Appeal

In 2018, the devices with vertical orientation is estimated to surpass other variants and account for over ½ of the global vacuum mixing devices-derived value. Though end users will continue to invest in vertical vacuum mixing devices, the demand for rotational vacuum mixing devices will also see a considerable uptick through 2029, unveils FMI.

With ‘portable’ emerging as the new norm in the medical laboratory equipment space, manufacturers are jumping onto the ‘portability’ bandwagon by launching newer models of vacuum mixing devices that are easy-to-carry and compact in size. According to the FMI analysis, North America (29%) and Europe (26%) will continue to be the leading markets for vacuum mixing devices in 2019 and beyond, set in motion by robust healthcare infrastructure and massive investments in development of high-quality laboratory essentials.

Vacuum mixing devices worth ~ US$ 128 Mn were sold in hospitals in 2018, primarily driven by the growing number of inpatient and outpatient procedures. Manufacturers, to draw upon this increase in demand, are focusing on effective marketing of their products to hospitals by using ‘easy-to-use’ and ‘compatibility with varying viscosities’ as two of their key marketing touchpoints. However, various regulations put in place for manufacturing of vacuum mixing devices will continue to impede its penetration by increasing the ‘time-to-market’ factor.

Key Market Segments Covered in Vacuum Mixing Devices Industry Research

By Product:

Vertical Vacuum-Mixing Devices
Rotational Vacuum-Mixing Devices
Vertical+Twisting Vacuum-Mixing Devices

By Modality:

Bench Top Devices
Portable Devices

By End User:

Ambulatory Surgical Centers
Hospitals
Specialty Clinics

Author by

Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us: